In this study, we aimed to assess SLC7A8 gene copy number (CN) and mRNA expression, alongside SLC7A8 protein expression in large and well-characterised cohorts of BC to determine its clinicopathological and prognostic value with emphasis on the different molecular classes. This evidence concerns the gene SLC7A8 and breast cancer.